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accinia virus (VV) egress has been studied using
confocal, video, and electron microscopy. Previ-
ously, intracellular-enveloped virus (IEV) particles
were proposed to induce the polymerization of actin tails,
which propel IEV particles to the cell surface. However,
data presented support an alternative model in which mi-
crotubules transport virions to the cell surface and actin
tails form beneath cell-associated enveloped virus (CEV)
particles at the cell surface. Thus, VV is unique in using
both microtubules and actin ﬁlaments for egress. The fol-
lowing data support this proposal. (a) Microscopy detected
actin tails at the surface but not the center of cells. (b) VV
V
 
mutants lacking the A33R, A34R, or A36R proteins are un-
able to induce actin tail formation but produce CEV and
extracellular-enveloped virus. (c) CEV formation is inhib-
 
ited by nocodazole but not cytochalasin D or 4-amino-
 
5-(4-methylphenyl)-7-(t-butyl)pyrazolo(3,4-d)pyrimidine
(PP1). (d) IEV particles tagged with the enhanced green ﬂu-
orescent protein fused to the VV B5R protein moved inside
 
cells at 60 
 
 
 
m/min. This movement was stop-start, was
along deﬁned pathways, and was inhibited reversibly by
nocodazole. This velocity was 20-fold greater than VV
movement on actin tails and consonant with the rate of
movement of organelles along microtubules.
 
Introduction
 
Vaccinia virus (VV)* replicates in the cytoplasm and forms
two distinct infectious virions termed intracellular mature
virus (IMV) and extracellular enveloped virus (EEV) (Apple-
yard et al., 1971; Ichihashi et al., 1971). IMV particles are
formed in cytoplasmic factories (Dales and Mosbach, 1968)
from where they are transported in a process that requires
the VV A27L gene product and microtubules (Sanderson et
al., 2000). Subsequently, IMV particles are wrapped by a
double membrane (Ichihashi et al., 1971; Morgan, 1976;
Payne and Kristensson, 1979) derived from tubular endo-
somes (Tooze et al., 1993) or the trans-Golgi network
(Hiller and Weber, 1985; Schmelz et al., 1994) to form in-
tracellular enveloped virus (IEV). IEV moves to the cell sur-
face where the outer membrane fuses with the plasma mem-
brane to form cell-associated enveloped virus (CEV) that
remains on the cell surface (Blasco and Moss, 1992) or EEV
that is released from the cell. CEV is important for virus
spread between adjacent cells, and EEV mediates the long-
range dissemination of virus (Ichihashi et al., 1971; Boulter
and Appleyard, 1973; Payne, 1980; Payne and Kristensson,
1985; Blasco and Moss, 1992).
During VV infection, the host cell cytoskeleton undergoes
changes, with actin stress fibers disappearing and thickened
actin tails becoming visible with virus particles at their tips
(Stokes, 1976; Hiller et al., 1979; Krempien et al., 1981;
Hiller and Weber, 1982; Blasco et al., 1991; Cudmore et al.,
1995). It was proposed that actin tails form on IEV particles
and drive these virions to the cell surface (Cudmore et al.,
1995, 1996, 1997). This proposal was consistent with the
observation that IEV particles are needed for actin tail for-
mation (Cudmore et al., 1995; Wolffe et al., 1997, 1998;
Sanderson et al., 1998; Zhang et al., 2000) but inconsistent
with the fact that virus mutants lacking the A33R, A34R, or
A36R proteins or with mutations in the B5R protein are un-
able to make actin tails but still produce CEV and EEV and
sometimes at levels greater than wild-type virus (McIntosh
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and Smith, 1996; Wolffe et al., 1997; Mathew et al., 1998;
Roper et al., 1998; Sanderson et al., 1998; Wolffe et al.,
1998; Röttger et al., 1999). The proposal was also inconsis-
tent with the observation that CEV particles are formed in
the presence of cytochalsin D (Payne and Kristensson,
1982). Therefore, an alternative mechanism for IEV trans-
port to the cell surface must exist.
The wrapping of IMV by intracellular membranes re-
quires the interaction of virus protein(s) on the IMV sur-
face and the cytosolic face of the wrapping membranes.
Proteins required for wrapping include the A27L protein
on IMV (Rodriguez and Smith, 1990; Sanderson et al.,
2000) and the EEV proteins F13L (Hirt et al., 1986) and
B5R (Engelstad and Smith, 1993; Wolffe et al., 1993). In
 
addition, wrapping is inhibited reversibly by 
 
N
 
1
 
-isonico-
tinoyl-
 
N
 
2
 
-3-methyl-4-chlorobenzoylhydrazine (IMCBH)
(Payne and Kristensson, 1979). Actin tails mediate effi-
cient cell-to-cell virus spread because mutants deficient in
their formation produce a small plaque (Cudmore et al.,
1995; Sanderson et al., 1998; Wolffe et al., 1998; Zhang et
al., 2000).
Actin tail formation by VV (Cudmore et al., 1995) has
similarities with 
 
Shigella
 
, 
 
Listeria, 
 
and 
 
Rickettsia
 
 (Frisch-
knecht and Way, 2001). However, whereas these bacteria
polymerize actin from one end of the bacterium due to the
polarized distribution of specific proteins, no VV protein
with asymmetrical distribution on the surface of the IEV
particles has been reported (Schmelz et al., 1994; Röttger et
al., 1999; van Eijl et al., 2000). Indeed, the VV A36R pro-
tein that is required for polymerization of actin tails (Sander-
son et al., 1998; Wolffe et al., 1998; Röttger et al., 1999)
seems evenly distributed on the IEV surface (van Eijl et al.,
2000). Therefore, if actin polymerizes on IEV particles it is
unknown how this is polarized.
An alternative proposal was that VV-induced actin tails
grow beneath the plasma membrane rather than on IEV par-
ticles (van Eijl et al., 2000). Immunoelectron microscopy
showed that the A36R protein was absent from CEV parti-
cles but present on the cytosolic face of the plasma mem-
brane beneath CEV in a position to polymerize actin and
drive these virions away from the cell (van Eijl et al., 2000).
Moreover, A36R mutagenesis showed that A36R tyrosine
phosphorylation by a Src-family kinase is essential for actin
tail formation, and this process is inhibited by 4-amino-
 
5-(4-methylphenyl)-7-(t-butyl)pyrazolo(3,4-d)pyrimidine
(PP1) and mimics receptor tyrosine kinase signaling at the
cell surface (Frischknecht et al., 1999).
In this study, we have reexamined the distribution of IEV
and CEV particles by confocal, video, and electron micros-
copy after infection with wild-type and mutant viruses, in-
cluding a new virus in which the enhanced green fluorescent
protein (EGFP) is fused to the outer membrane of IEV par-
ticles. These infected cells were also treated with drugs that
prevent the wrapping of IMV to form IEV or that disrupt
microtubules or actin filaments. We show that IEV particles
utilize microtubules to facilitate their intracellular transport
to the plasma membrane, and actin tails form from the cell
surface beneath CEV particles to aid their dissemination.
This represents the first example of a virus that utilizes both
microtubules and actin for egress from the cell.
 
Results
 
Analysis of actin tail distribution by phase–contrast 
and confocal microscopy
 
Phase–contrast microscopy of VV-infected cells reveals
phase-dense virus particles and virus-induced actin tails (Fig.
1 A). However, it is not possible to determine if the actin
tails are below, within, or above the cell. To investigate their
location, infected cells were stained with rhodamine-phalloi-
din and analysed by confocal microscopy. Fig. 1 B shows a
single optical section at the bottom of the cell and three sets
of arrows/arrowheads indicate positions of actin tails. Fig. 1,
C–E, shows vertical optical sections of this infected cell in-
cluding the actin tails marked in Fig. 1 B. Panels F and G,
show parts of panels B and E at higher magnification, and
the two arrows show the position of the same actin tails in
the horizontal (Fig. 1 F) and vertical (Fig. 1 G) sections. All
actin tails (
 
 
 
15 in Fig. 1 G) were located at the cell surface
or between the cell and the tissue culture support. Notably,
all the vertical sections of these and other cells (
 
n
 
 
 
 
 
 25)
failed to detect actin tails within the cell body away from the
cell surface.
The three-dimensional distribution of virus particles and
actin tails was studied in more detail by collecting horizontal
optical sections starting at the basal lateral cell surface and
moving in 0.5-
 
 
 
m steps up through the cell. When the im-
ages were condensed as a single plane (Fig. 2 A), phalloidin-
stained actin tails appeared constrained within the cell
boundary and projecting away from the cell. Representative
z-sections from Fig. 2 A are shown in Fig. 2, B–E, with one
cell boundary outlined. Actin tails are visible close to the
bottom (Fig. 2 B) and top of the cell (Fig. 2 E) or near the
cell periphery (Fig. 2 D) but not within the cell lumen mid-
way through the z-series (Fig. 2 C). A vertical section (Fig. 2
F) shows two actin tails (arrows) that are also marked in
panel B. One tail is at the bottom of the cell, whereas the
other protrudes away from the cell. As in Fig. 1, actin tails
were not observed within the cytoplasm separated from the
plasma membrane. Fig. 2 G is a stereo image of the z-sec-
tions of Fig. 2 A in which the three-dimensional organiza-
tion of actin fibers and virus-induced actin tails can be ob-
served more clearly.
 
Analysis of actin tail distribution by EM
 
The optical sections taken close to the basolateral cell mem-
brane (Fig. 1, B and F, and Fig. 2 B) showed actin tails, but
it was not evident if these and others were within or beneath
the cell. This was studied by EM of vertical sections of in-
fected cells. Fig. 3 A shows some electron-dense IEV and
CEV particles and an actin tail protruding into the space be-
tween the culture support and the cell. In this example, the
distinctive actin tail does not possess a virus particle at its
tip, perhaps because it is located in another plane or has
been released already. Fig. 3 B shows additional examples of
actin tails beneath the cell, in some cases with a CEV at their
tip. Such actin tails have little space into which to extend
and so might push back into the cell. A virus particle at the
tip of such an actin tail would appear to be within the cell,
and an image of an intracellular virus-tipped actin tail has
been published (Cudmore et al., 1995). However, a virion at
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the tip of an actin tail that has reentered the cell can be dis-
tinguished from an actin tail that polymerized from an IEV
particle within a cell by whether or not it was associated with
additional cellular membranes. An IEV particle that poly-
merized actin would have no membrane bordering the actin
tail. In contrast, an actin tail that had grown from the cell
surface and then reentered the cell would be surrounded by
two membranes, representing the plasma membranes ac-
quired during actin tail formation and during protrusion
back into the cell. Fig. 3 C shows a virus-tipped actin tail
protruding from one cell (bottom) into another cell (top)
and membranes down either side of the tail. In addition, the
outer membrane encloses the CEV particle at the tip of the
actin tail. Fig. 3, D–F, shows an additional example taken
from deeper within the cell. In Fig. 3 D, the number of
membranes surrounding the virus particle and tail are not
well discerned. However, when the sample is tilted 
 
 
 
 35
 
 
 
 in
the electron beam (Fig. 3, E and F) the membranes down ei-
ther side of the actin tail become clear. The insets show a
higher magnification of the multiple membranes on either
side of this CEV particle. The example shown in Fig. 3, D–F,
illustrates the rare situation where a CEV particle has reen-
tered the cell and appears as an intracellular particle associated
with an actin tail. In contrast, it was easy to find numerous
IEV particles, none of which were associated with actin tails,
and numerous CEV particles that were associated with actin
tails (for examples see Figs. 3 and 4).
The characteristic and uniform electron density of the ac-
tin tails compared with the cell cytoplasm (Fig. 4 F) provides
additional evidence that actin tails are growing from the cell
surface (Figs. 3 and 4). If an actin tail was polymerizing from
an IEV particle within a cell, the characteristic electron den-
sity of the actin tail would extend from deeper within that
cell and not just from the cell surface as occurs in Fig. 3 C.
This was examined further in Fig. 4, A–E, in which serial
sections were cut to search for actin tails that might extend
from deeper within the cell in a different section plane. The
images show several actin tails emerging from a similar loca-
tion on the cell surface. These are of different lengths out-
side the cell, and in several of the sections a CEV particle is
Figure 1. Distribution of actin tails in infected cells. (A) Phase–contrast microscopy. BS-C-1 cells were infected with VV at 1 PFU/cell and 
at 12 hpi fixed with methanol and photographed under phase–contrast. The actin tails with dense particles at their tips are visible. (B) Confo-
cal microscopy. RK13 cells were infected with VV as in A and fixed and permeabilized at 9 hpi. Cells were stained with rhodamine-conju-
gated phalloidin, and a single optical section at the base of the cell is shown. Arrows denote pairs of actin tails that are also illustrated in the 
vertical optical section shown in C–E. F is a magnification of B, showing two actin tails that are shown in the vertical section in G. Bars, 5  m.
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visible at the tip of the actin tail. However, in no case (
 
n
 
 
 
 
 
100) was there evidence of actin tails extending into the
granular cytoplasm of the cell.
 
Actin tail formation by CEV particles requires 
microtubule-dependent IEV particle egress
 
Since actin tails are formed from the cell surface, we inves-
tigated if microtubules facilitate IEV egress by using the mi-
crotubule-depolymerizing drug nocodazole (Storrie et al.,
1998). However, because microtubules are needed for the
movement of IMV particles from the virus factory to the site
of wrapping to form IEV particles (Sanderson et al., 2000),
nocodazole would prevent the formation of IEV and CEV
particles and thereby actin tails indirectly. Therefore, we used
the drug IMCBH that arrests morphogenesis, reversibly, after
IMV but before IEV formation (Payne and Kristensson,
1979; Schmutz et al., 1991) and studied actin tail formation
after IMCBH washout in the presence or absence of nocoda-
zole (Fig. 5). Without IMCBH treatment, actin tails are evi-
dent, protruding from VV-infected cells (Fig. 5 A), whereas
in the presence of IMCBH actin tails are not formed, and
there are a greater number of actin stress fibers (Fig. 5 B), a
feature characteristic of virus mutants unable to make actin
tails (Sanderson et al., 1998). These data are consistent with
Figure 2. VV-induced actin tails are 
formed from the cell surface. RK13 cells 
were infected with VV, stained with 
phalloidin, and analyzed by confocal 
microscopy as described in the legend to 
Fig. 1 B. A shows a z-series reconstruc-
tion (17 sections), and G shows this pro-
jection as a stereo anaglif. B–E show 
projections of individual optical sections 
moving from the basolateral (B) to the 
apical surface (E). The outline of the cell 
is drawn with a dotted line. F shows a 
vertical section of the cell illustrating the 
positions of the actin tails shown in B. 
Arrows in B and F mark the same actin 
tails. Bar, 5  m.
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previous observations (Cudmore et al., 1995). Within 60
min of IMCBH washout, numerous actin tails are evident
(Fig. 5 C). However, if IMCBH is washed out in the pres-
ence of nocodazole, actin tails are not formed (Fig. 5 D).
The effect of nocodazole on the distribution of VV parti-
cles was investigated by immunofluorescence. Cells were in-
fected for 11.5 h and then incubated with or without drug
for 1.5 h and stained for VV protein B5R (Fig. 6). Without
nocodazole clusters of VV, particles are seen in peripheral re-
gions of the cell (Fig. 6 A), and this clustering is inconsistent
with the movement of IEV particles driven by actin tails,
which would be random. In contrast, in the presence of
nocadazole VV particles were distributed randomly in the
cytoplasm consistent with the fragmentation of the microtu-
bular network (Fig. 6 B).
 
Inhibition of tyrosine phosphorylation by PP1 blocks 
actin tail but not CEV particle formation
 
Drug PP1 inhibits tyrosine phosphorylation of the A36R
protein and thereby prevents actin tail formation (Frisch-
knecht et al., 1999). Here we used PP1 to investigate
whether CEV particles were formed in the absence of
A36R phosphorylation and actin tail formation. At 5 hours
postinfection (hpi), cells were incubated in the presence or
absence of PP1 for 6 h before staining live cells with mono-
clonal antibody (mAb) 19C2 to detect surface B5R pro-
Figure 3. EM of VV-tipped actin tails. 
HeLa cells were infected with VV at 1 
PFU/cell and processed for thin section 
transmission electron microscopy at 9 
hpi. (A and B) Vertical section through 
the infected cell; note the tissue culture 
plastic (arrowheads). (A) Basolateral re-
gion showing IEV and CEV particles and 
an actin tail protruding into the space be-
tween the cell surface and the tissue cul-
ture plastic. (B) Further examples of actin 
tails and CEV particles beneath the cell. 
(C–F) CEV particles pushing into neigh-
boring cells on actin tails. In E and F, the 
sample shown in D has been tilted   35 , 
respectively, to bring the membranes into 
focus. Arrows in the magnified inserts 
highlight the membranes surrounding the 
actin tail and CEV particle. Bars: (A) 1 
 m; (B–D) 500 nm; (F, inset) 100 nm.
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tein. Similar densities of cell surface CEV particles were
seen in the presence and absence of PP1, indicating that
the inhibition of actin tail formation did not prevent
movement of enveloped virions to the cell surface (Fig. 6,
C and D). Staining of infected cells with phalloidin (Fig.
6, E–F) confirmed that actin tail formation was inhibited
by PP1.
 
CEV particle formation requires microtubules but 
neither the A36R protein nor actin tails
 
To confirm that the ability of nocodazole and PP1 to inhibit
actin tail formation was not an indirect effect of these drugs
on virus morphogenesis, cells were analyzed by EM. In wild-
type VV-infected cells that had been treated with IMCBH
followed by drug washout in the presence of nocodazole, nu-
merous IEV particles were present (Fig. 7 A), but CEV par-
ticles were not found at the plasma membrane. However, if
 
IMCBH was washed out in the presence of cytochalasin D
numerous CEV particles were visible (Fig. 7 B). Similarly, in
PP1-treated infected cells IEV were found inside the cell and
CEV particles were present on the plasma membrane (Fig. 7
C). Thus, although nocodazole and PP1 both prevent actin
tail formation, they inhibit virus egress at different stages:
nocodazole does not prevent IEV particle formation but in-
hibits movement of IEV particles to the cell surface, and
PP1 prevents actin tail formation from the cell surface be-
neath CEV particles. Cytochalasin D did not inhibit IEV
transport.
The v
 
 
 
A36R virus mutant (Parkinson and Smith, 1994)
that lacks the A36R protein and does not make actin tails was
also studied. EM of v
 
 
 
A36R-infected cells showed that CEV
particles are present on the cell surface (Fig. 7 D) consistent
with a previous report (Wolffe et al., 1998) and our own con-
focal data from live cells (unpublished data). This dem-
Figure 4. EM of serial sections. HeLa cells 
were infected with VV and processed for EM as 
described in the legend to Fig. 3. Consecutive 
sections (80-nm apart) from the basolateral sur-
face (A) going up into the cell (ending in E) are 
shown. F shows an electron density scan of the 
image shown in Fig. 3 D to illustrate the uniform 
electron density of the actin tail that is distinct 
from that of the surrounding cytosol. 8-Bit gray 
scale image coded for gray values 0–86   1, 
87–170   2, 171–190   3, and 191–255   4. 
Bar, 1  m.
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onstrated independently that actin tail formation is not neces-
sary for the movement of enveloped particles to the cell sur-
face.
 
Time-lapse photography of VV transport
 
To study the movement of IEV particles in live cells, we
constructed a VV mutant in which the IEV particles were
tagged with EGFP fused to the B5R protein. Mutagenesis of
the B5R protein had shown that the transmembrane and cy-
toplasmic domains of this type I membrane protein are suffi-
cient to direct antigens onto EEV (Katz et al., 1997), and
deleting the extracellular domain of B5R did not prevent
IEV formation (Herrera et al., 1998; Mathew et al., 1998).
Therefore, the extracellular domain of B5R was replaced by
EGFP, and the chimeric gene was inserted into VV strain
Western reserve (WR), replacing the natural B5R gene. Cells
infected with this virus synthesized a 40-kD protein that was
recognized by an anti-EGFP antibody (unpublished data).
EM showed that virus morphogenesis was unaltered by this
change (Fig. 8, A, C, and E), and immunoelectron micros-
copy showed that the B5R-EGFP protein was incorporated
into IEV and CEV but not IMV particles (Fig. 8, B, D, and
F). Staining of infected cells with rhodamine-phalloidin re-
vealed that virus-induced actin tails were not made (unpub-
lished data), but nonetheless CEV particles were detected by
EM (Fig. 8 E).
Live cells infected with vB5R-EGFP were analysed by
time-lapse confocal microscopy to study transport of IEV
particles to the cell surface. In Fig. 9, the position of a single
IEV particle is shown at 3-s intervals, and measurement of
the distance travelled indicated that this particle moved at 40
 
 
 
m/min. Measurements of 10 other particles gave similar ve-
locities (range, 40–98 
 
 
 
m/min; mean, 60). This velocity is
similar to that mediated by microtubules but not actin
Figure 5. Microtubules and IEV parti-
cles are required for the formation of ac-
tin tails. RK13 cells were infected with VV 
at 10 PFU/cell in either the absence (A) or 
presence (B–D) of IMCBH. At 8 hpi, the 
cells in C and D were washed three times 
in DME (C) or in DME containing 33  M 
nocodazole (D). 1 h later, all cells were 
fixed and stained with rhodamine-conju-
gated phalloidin as described in Materi-
als and methods. Samples were analyzed 
by confocal microscopy, and the recon-
structed z-series are shown. Bar, 10  m.
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(Trinczek et al., 1999; Sodeik, 2000). In addition, treatment
of cells with nocodazole blocked IEV particle movement, and
this was reversed by washout of the drug (unpublished data).
Lastly, the relative locations of microtubules and IEV par-
ticles were examined (Fig. 10). Virions were identified by
DIC microscopy (Fig. 10 A) and stained with DAPI (Fig. 10
C), IEV particles were visualized by virtue of their EGFP
(Fig. 10 B), and microtubules were stained with an antitu-
bulin mAb (Fig. 10, D–F). Although the microtubule net-
work was reported to be disrupted by VV infection (Plou-
bidou et al., 2000), we found a normal distribution of
microtubules (Fig. 10 E) late during infection after new vi-
rus particles were disseminated. When the 
 
 
 
-tubulin and
EGFP images were merged, many of the IEV particles were
coincident with microtubules (Fig. 10 E), and this is more
apparent at higher magnification (Fig. 10, F and G). This
provides direct evidence for colocalization of IEV particles
and microtubules.
 
Discussion
 
VV infection induces virus-tipped actin tails that were pro-
posed to form on IEV particles and propel these virions to
the cell surface at a rate of 2.8 
 
 
 
m/min (Cudmore et al.,
1995, 1996, 1997). At the cell surface, actin tails drive CEV
particles away from the cell or into neighboring cells at the
same rate. There is substantive evidence that actin tails are
needed for efficient cell-to-cell spread of virus, since mutant
viruses that lack proteins A33R, A34R, A36R, B5R, F12L,
or F13L produce few if any tails and form a small plaque.
However, the site of actin tail formation was less clear, and
in this paper we demonstrate that actin tails form beneath
CEV particles at the cell surface rather than on IEV particles
intracellularly. Instead of virions moving to the cell surface
in an actin-dependent manner, we demonstrate that this
process requires microtubules.
Several observations are inconsistent with the view that ac-
tin tails form on IEV particles. First, it was reported that cy-
Figure 6. Confocal microscopy of VV-
infected cells. (A–B) Microtubules are 
needed for IEV transport to the cell pe-
riphery. RK13 cells were infected with VV 
at 1 PFU/cell for 11.5 h. The medium 
was replaced by either fresh DME (A) or 
DME containing 33  m nocodazole (B). 
At 13 hpi, the cells were fixed, permeabi-
lized, and stained with Mab 19C2 (anti-
B5R). Arrows indicate clusters of virus 
particles near the cell surface. (C–F) PP1 
blocks the formation of actin tails but not 
CEV particles. RK13 cells were infected 
with VV at 1 PFU/cell, and at 5 hpi PP1 
was added to a final concentration of 20 
 M. (C and D) At 11 hpi, the medium 
was replaced with DME containing mAb 
19C2 (anti-B5R) (live cells), and the cells 
were incubated for 1 h before fixation 
and processing for fluorescent micros-
copy. (E and F) Cells were fixed at 12 hpi 
and stained with and rhodamine-conju-
gated phalloidin. Bars, 10  m.
 
o
n
 
A
p
r
i
l
 
3
0
,
 
2
0
0
8
 
w
w
w
.
j
c
b
.
o
r
g
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
  
Vaccinia virus egress uses microtubules |
 
 Hollinshead et al. 397
 
tochalasin D did not prevent the formation of CEV particles
(Payne and Kristensson, 1982). Second, some virus mutants
that are unable to form actin tails can release enhanced levels
of EEV (McIntosh and Smith, 1996; Wolffe et al., 1997;
Mathew et al., 1998; Sanderson et al., 1998). Third, no vi-
rus protein needed for actin tail formation has an asymmet-
ric distribution on IEV particles such that actin would poly-
merize on only one side of the virion. Lastly, the A36R
protein, which is essential for actin tail formation, is located
beneath CEV particles on the cytosolic face of the plasma
membrane in a position to induce actin tails from the cell
surface (van Eijl et al., 2000). These data prompted us to re-
investigate the site of actin tail formation and how IEV par-
ticles move to the cell surface.
The original reports proposing actin tails formed on IEV
particles (Cudmore et al., 1995, 1996) did not distinguish
between IEV and CEV particles moving on actin tails. Un-
der the light microscope, although virus particles and actin
tails are visible (Fig. 1) it is impossible to determine their ex-
act location because of the lack of resolution. Therefore, we
used confocal microscopy that can section cells vertically or
horizontally and thereby analyze where actin tails are lo-
cated. These analyses demonstrated that actin tails were lo-
cated close to the cell periphery at the top, bottom, or edge
of the cell but not within the cytoplasm distinct from the
cell plasma membrane (Figs. 1 and 2).
EM also provided data consistent with this view. Al-
though a virus-tipped actin tail was sometimes found within
an infected cell, these are CEV particles that have reentered
the cell driven by an actin tail rather than an IEV particle
that induced actin polymerization. This distinction was
straightforward: the actin tail was bordered by two mem-
branes derived from the plasma membrane as the CEV left
and then reentered the cell (Fig. 3), whereas an actin tail on
an IEV particle would lack these membranes. Such mem-
branes were not observed previously, probably because the
HeLa cells were permeabilized with streptolysin 
 
O
 
 and then
treated with S1 myosin before analysis by EM (Cudmore
et al., 1995, 1996). The cellular ultrastructure, including
membranes, is poorly conserved by this technique.
EM showed also that the characteristic electron density of
the actin tail started from the cell surface rather than from
deeper within the cell. To be sure that actin tails that might
have extended from deeper within the cell cytoplasm to the
cell surface had not been missed in another plane, the sam-
ples were subjected to serial section analysis (Fig. 4). Al-
though many actin tails of differing lengths extended from
the cell surface, in no case were actin tails observed extend-
ing from deep within the cell. The presence of actin tails of
differing lengths suggested that the failure to observe actin
tails within the cytoplasm was not due to depolymerization
of these structures.
The site of actin tail formation was also investigated in
cells infected with wild-type VV and then treated with spe-
cific drugs or after infection with mutant virus. IMCBH
blocks the wrapping of IMV particles by cellular mem-
Figure 7. EM of infected cells. RK13 cells were 
infected with VV (A–C) or v A36R (D) at 1 PFU/
cell. Cells in A and B were treated with IMCBH 
and either nocodazole (A) or cytochalasin D (B) 
as described in the legend to Fig. 5. In C, PP1 
was present from 5 to 11 hpi. In D, v A36R-in-
fected cells were harvested at 12 hpi. All cells 
were processed for thin section transmission 
electron microscopy. Bars, 250 nm.
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branes. However, this process is restored after removal of the
drug. When the drug was washed out in the presence of no-
codazole, actin tails were not formed (Fig. 5). Under these
conditions, EM showed that IEV particles were still formed,
but these were not transported to the cell surface (Fig. 7).
Moreover, immunofluorescent microscopy showed that the
clustering of virus particles near or on the cell surface was
prevented (Fig. 6). In contrast, washout of IMCBH in the
presence of cytochalasin D did not prevent CEV formation
(Fig. 7). Collectively, these data show a requirement for mi-
crotubules and not actin for the movement of IEV particles
to the cell surface.
In another approach, we used the drug PP1 that inhibits
tyrosine phosphorylation, since tyrosine phosphorylation of
the A36R protein is essential for actin tail formation (Frisch-
knecht et al., 1999). After treatment of cells with PP1, CEV
particles were seen on the cell surface by fluorescent and
electron microscopy, yet under the same conditions actin
tails were not formed (Figs. 6 and 7). Similarly, the VV mu-
tant lacking the A36R protein (Parkinson and Smith, 1994)
does not make actin tails (Sanderson et al., 1998; Wolffe et
al., 1998; Röttger et al., 1999), but nevertheless numerous
CEV particles were seen at the cell surface (Fig. 7 D).
Lastly, we constructed and analysed a VV mutant that ex-
presses EGFP fused to B5R on the surface of IEV particles.
Time-lapse photography showed that individual virus parti-
cles moved in infected cells at rates of 40–98 
 
 
 
m/min,
(mean, 60; SEM 
 
 
 
 5; 
 
n 
 
 
 
 10). This speed is similar to that
for microtubular transport and is 20-fold greater than VV
movement on actin tails (2.8 
 
 
 
m/min) (Cudmore et al.,
1995). Furthermore, the movement of IEV particles was
stop-start in nature, was along defined pathways rather than
being random in the cytosol, and was inhibited reversibly by
nocodazole. Finally, we showed that EGFP-positive IEV
particles colocalized with microtubules in infected cells and
that after IEV particles had been produced the microtubule
network remained intact, in contrast to a previous report
(Ploubidou et al., 2000).
The transport of IMV particles away from virus factories
requires microtubules and the A27L gene product (Sander-
Figure 8. VV morphogenesis in cells infected with 
vB5R-GFP. RK13 cells were infected with vB5R-EGFP 
and processed for conventional EM after fixation at 12 
hpi (A, C, and E). Alternatively, samples were pro-
cessed for cryo-immunoelectron microscopy and la-
beled with anti-GFP and protein A gold (B, D, and F). 
Bars, 300 nm.
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son et al., 2000). Thus, VV requires microtubules at two
stages during virus egress, and the revised model for VV
egress is summarized in Fig. 11. Although, a VV protein on
the surface of the IMV particle has been identified that is
necessary for the microtubule-mediated movement of IMV
particles, no such protein on the surface of IEV particles has
been reported. In all cases where IEV- or EEV-specific genes
have been deleted, the wrapping of IMV particles is either
inhibited (B5R or F13L) or IEV particles are formed and
transported to the cell surface. A mutant that forms IEV par-
ticles that are not transported would be useful for investiga-
tion of IEV–microtubule interactions.
The revised model of VV egress presented here (Fig. 11)
shows that VV and intracellular bacteria differ in the uti-
lization of actin polymerization for their dissemination.
Whereas these bacteria polymerize actin from one end of the
bacterium within the cytosol and use the growing actin tails
for movement within and out of the cells, VV polymerizes
actin tails from the plasma membrane beneath virus particles
on the cell surface. These virions are then driven away from
the cell to infect new cells.
The polymerization of actin beneath CEV particles pro-
vides a plausible explanation for the existence of CEV. Ini-
tially, it might seem surprising that the majority of virus that
reaches the cell surface is retained rather than released. In-
deed several viruses, for example influenza virus, express re-
ceptor-destroying enzymes to prevent aggregation of new
virions on the cell surface or with each other. However, VV
needs to retain enveloped virus on the cell surface long
enough for the polymerization of actin to take place and
drive the virions into surrounding cells.
In conclusion, we show that microtubules but not actin
tails are used to facilitate transport of IEV particles to the
cell surface, and the actin tails form beneath CEV particles
at the cell surface to drive virus particles away from the cell.
Although other viruses such as adenovirus (Suomalainen et
al., 1999), herpes simplex virus (Sodeik et al., 1997), and
African swine fever virus (Carvalho et al., 1988) use micro-
Figure 9. Real time movement of CEV particles in 
infected cells. Images from a single optical plane of a 
cell 8 hpi with vB5R-EGFP were taken at 3-s intervals. 
(A) Projection of movement of vB5R-EGFP over 18 s. 
B–H show the position of the single particle (arrow-
head) at 3-s intervals. Calculated speed of movement 
40  m/min. Bar, 10  m.
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tubules for intracellular transport, VV egress is unique in ex-
ploiting both microtubules and actin for dissemination.
 
Materials and methods
 
Cells, viruses, and drugs
 
BS-C-1, HeLa, and RK
 
13
 
 cells were grown in MEM supplemented with 10%
FBS (GIBCO BRL). VV strain WR and a mutant lacking the A36R gene (Par-
kinson and Smith, 1994) were used. IMCBH was provided by R. Wittek
(University of Lausanne, Lausanne, Switzerland). Nocodazole (Sigma-
Aldrich), cytochalasin D (Sigma-Aldrich), and PP1 (Alexis Biochemicals)
were added to a final concentration of 33, 1, and 20 
 
 
 
M, respectively.
 
Phase–contrast and DIC microscopy
 
A Zeiss Axioplan II microscope with a 100
 
 
 
 objective was used, and im-
ages were acquired with a Eastman Kodak Co. Spot 2 CCD camera.
 
Fluorescent microscopy
 
Cells growing on glass coverslips (Chance Proper, Ltd.) were infected with
VV for 1 h at 1 PFU/cell and at the indicated time postinfection were fixed
in paraformaldehyde as described (van Eijl et al., 2000). Cells were blocked
and permeabilized for 5 min at room temperature in PBS containing 0.1%
saponin and 10% FBS. Alternatively, infected cells were fixed for 5 min at
 
 
 
20
 
 
 
C in methanol. To identify VV particles, cells were incubated with
mAb 19C2 (Schmelz et al., 1994) that recognizes the VV B5R protein.
Bound mAb was detected by FITC-conjugated goat anti–rat IgG (mouse-
adsorbed) antibody (Stratech Scientific) (diluted 1:200). F-actin was stained
with TRITC-phalloidin (Sigma-Aldrich) (diluted 1/100). Cells were analyzed
using a Bio-Rad Laboratories MicroRadiance confocal laser scanning mi-
croscope as described (Sanderson et al., 1998). Images were collected and
processed using Lasersharp and Adobe Photoshop
 
®
 
 software. Live cells
were stained with mAb 19C2 as described (van Eijl et al., 2000). Microtu-
bules were identified by staining fixed cells with an antitubulin rat
mAbYOL-1/34 (Serotech) (diluted 1:50) and rhodamine-conjugated donkey
anti–rat IgG (mouse-adsorbed) antibody (diluted 1:100) (Stratech Scientific).
 
Live cell imaging
 
BS-C-1 cells were infected with vB5R-EGFP for 2 h at 10 PFU/cell. At 8
hpi, time-lapse images of the infected cells maintained at 37
 
 
 
C on a heated
microscope stage were recorded using a Bio-Rad Laboratories 1024 confo-
cal laser scanning microscope. Images were collected every 3 s using La-
sersharp software and processed using Adobe Photoshop
 
®
 
 software.
 
Preparation of samples for EM
 
BS-C-1, HeLa, and RK
 
13
 
 cells were infected with VV at 1 PFU/cell and at
the indicated times after specific treatments and processed for thin section
transmission electron microscopy as described (Hollinshead et al., 1999).
For immunoelectron microscopy, ultrathin cryosections were labeled with
anti-GFP (CLONTECH) (diluted 1:10). All digital images were captured
with the integrated SIS image analysis package (Soft Imaging Software) and
processed using Adobe Photoshop
 
®
 
 software.
 
Construction of recombinant virus expressing EGFP
 
To follow the movement of IEV particles, a recombinant VV was con-
structed in which EGFP was fused to the transmembrane and cytoplasmic
domains of protein B5R. The chimeric gene was assembled in a plasmid
vector by PCR and splicing by overlap extension (Horton et al., 1989).
Plasmid pSTH2 (Engelstad et al., 1992) containing the VV WR B5R gene
and flanking sequences cloned into pUC13 was used as template for PCRs.
Oligonucleotides (1) 5 -TCATTTAAGCTTCCTTCTTTCGTGAAATGC-3 
and (2) 5 -CTCGCCCTTGCTCACTGTTGAATAAACAAC-3   generated a
fragment containing 322 bp upstream of the B5R ORF and B5R amino ac-
ids 1–20, including the signal peptide. Oligonucleotides (3) 5 -GAC-
GAGCTGTACAAGGAAGAATTTGATCCA-3  and (4) 5 -GTACTCAAGCT-
TGCTTACAGAAACATCGCGTT-3  generated a fragment encoding B5R
amino acids 242–317, including the transmembrane and cytoplasmic do-
mains and 337 nucleotides downstream. The EGFP ORF was amplified by
Figure 10. Colocalization of microtubules and IEV particles. Cells were infected with vB5R-EGFP and at 8 hpi fixed and stained with a mAb 
against  -tubulin (D) or with DAPI (C). In B, the positions of VV particles containing EGFP are shown, and the same virions were imaged by 
DIC microscopy (A). A merged image of  -tubulin and EGFP images is shown in E. (F and G) Higher magnification images of part of E. Bars: 
(A–E) 10  m; (F–G) 1  m.
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PCR using pEGFPC1 (CLONTECH) as template and oligonucleotides (5) 5 -
GTGAGCAAGGGCGAG-3  and (6) 5 -CTTGTACAGCTC-3 . Oligonucle-
otides (1) and (4) introduced HindIII restriction sites (underlined), whereas
primers (2) and (3) contained EGFP sequences, enabling the individual
fragments to be assembled into a single 1680-bp gene. This was digested
with HindIII and cloned into HindIII-digested pSJH7 (Hughes et al., 1991)
to form pB5R-EGFP. The fidelity of the cloned PCR product was confirmed
by sequencing.
The recombinant VV vB5R-EGFP was constructed by transient domi-
nant selection (Falkner and Moss, 1990). Cells infected with VV strain WR
at 0.1 PFU/cell were transfected with pB5R-EGFP and a virus in which the
wild-type B5R gene was replaced with EGFP-B5R, selected using pub-
lished methods (Parkinson and Smith, 1994), and called vB5R-EGFP.
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